Led Tamarind Bio’s $12M Series A as part of a $13.6M fundraise for AI drug discovery infrastructure.
Tamarind Bio provides AI infrastructure for biotech R&D, enabling scientists to design and optimize protein therapeutics, industrial enzymes, and peptides using state-of-the-art computational tools
Tamarind Bio provides AI infrastructure for biotech R&D, enabling scientists to design and optimize protein therapeutics, industrial enzymes, and peptides using state-of-the-art computational tools.